Commentary STAT First Opinion: Right-to-Try Legislation Offers False Hope and Would Endanger Patients January 16, 2018
Commentary FDA Lax in Evaluating Drugs Approved Through Expedited Pathways, Studies Show January 1, 2018
Commentary Outrage of the Month: Fake and Substandard Drugs Kill Hundreds of Thousands Around the Globe January 1, 2018
Commentary Outrage of the Month: Opioid Maker Executives “No Better Than Street-Level Drug Dealers” December 1, 2017